Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Santoro

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Arquivos Brasileiros De Endocrinologia E Metabologia|September 25, 2007
New drugs in thyroid cancerMassimo Santoro, Alfredo Fusco
The Journal of Clinical Investigation|October 29, 2013
Oncogenic rearrangements driving ionizing radiation-associated human cancerMassimo Santoro, Francesca Carlomagno
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancerMassimo Santoro, Francesca Carlomagno
Cancer Research|October 27, 2011
Is Co-option a prevailing mechanism during cancer progression?Marc Billaud, Massimo Santoro
Neural Regeneration Research|January 29, 2021
What do we know about the role of lncRNAs in multiple sclerosis?Viviana Nociti, Massimo Santoro
Cold Spring Harbor Perspectives in Biology|December 4, 2013
Central role of RET in thyroid cancerMassimo Santoro, Francesca Carlomagno
Arquivos Brasileiros De Endocrinologia E Metabologia|September 25, 2007
20 years of RET/PTC in thyroid cancer: clinico-pathological correlationsAlfredo Fusco, Massimo Santoro
Current Medicinal Chemistry|July 21, 2005
Receptor tyrosine kinases as targets for anticancer therapeuticsFrancesca Carlomagno, Massimo Santoro
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Targeting the RET pathway in thyroid cancerSamuel A Wells, Massimo Santoro
Endocrinology and Metabolism Clinics of North America|May 27, 2008
Dysregulated RET signaling in thyroid cancerMaria Domenica Castellone, Massimo Santoro
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Arquivos Brasileiros De Endocrinologia E Metabologia|September 25, 2007
New drugs in thyroid cancerMassimo Santoro, Alfredo Fusco
The Journal of Clinical Investigation|October 29, 2013
Oncogenic rearrangements driving ionizing radiation-associated human cancerMassimo Santoro, Francesca Carlomagno
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancerMassimo Santoro, Francesca Carlomagno
Cancer Research|October 27, 2011
Is Co-option a prevailing mechanism during cancer progression?Marc Billaud, Massimo Santoro
Neural Regeneration Research|January 29, 2021
What do we know about the role of lncRNAs in multiple sclerosis?Viviana Nociti, Massimo Santoro
Cold Spring Harbor Perspectives in Biology|December 4, 2013
Central role of RET in thyroid cancerMassimo Santoro, Francesca Carlomagno
Arquivos Brasileiros De Endocrinologia E Metabologia|September 25, 2007
20 years of RET/PTC in thyroid cancer: clinico-pathological correlationsAlfredo Fusco, Massimo Santoro
Current Medicinal Chemistry|July 21, 2005
Receptor tyrosine kinases as targets for anticancer therapeuticsFrancesca Carlomagno, Massimo Santoro
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Targeting the RET pathway in thyroid cancerSamuel A Wells, Massimo Santoro
Endocrinology and Metabolism Clinics of North America|May 27, 2008
Dysregulated RET signaling in thyroid cancerMaria Domenica Castellone, Massimo Santoro
Pageof 21